Cumberland Pharmaceuticals (CPIX) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.08%.
- Cumberland Pharmaceuticals' Return on Capital Employed rose 1500.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.14% for FY2024, which is 200.0% up from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.08% for Q3 2025, which was up 1500.0% from 0.07% recorded in Q2 2025.
- Cumberland Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.07% during Q2 2021, with a 5-year trough of 0.23% in Q3 2024.
- Its 5-year average for Return on Capital Employed is 0.11%, with a median of 0.09% in 2023.
- As far as peak fluctuations go, Cumberland Pharmaceuticals' Return on Capital Employed crashed by -1400bps in 2024, and later soared by 1500bps in 2025.
- Over the past 5 years, Cumberland Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.12% in 2021, then grew by 22bps to 0.09% in 2022, then tumbled by -87bps to 0.17% in 2023, then grew by 14bps to 0.14% in 2024, then skyrocketed by 47bps to 0.08% in 2025.
- Its Return on Capital Employed stands at 0.08% for Q3 2025, versus 0.07% for Q2 2025 and 0.07% for Q1 2025.